The results of these studies demonstrate that the antiproliferative and pro-apoptotic effects of ISO in breast cancer are mediated via inhibition of the AKT/mTOR and MEK/ERK signaling pathways and provide a basis for pursuing the therapeutic significance and chemopreventive capabilities of ISO in breast cancer. This evidence concerns the gene AKT1 and breast carcinoma.